Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya
Closed Posted
- Opportunity number
- RFA-JG-26-034
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications due
- Award size
- Up to $6,000,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Public)
- Other
- For Profit Organizations
- Non-501(c)(3) Nonprofits
- Small Businesses
- Higher Education Inst. (Private)
- Points of contact
-
- Jaya Raman kva5@cdc.gov
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention is soliciting applications for a cooperative agreement to conduct surveillance, epidemiologic, laboratory, clinical, and operations research on public health threats in Kenya, with applications due June 22, 2026. The CDC expects to make one award, subject to available funds and program priorities.
Eligible applicants include public and private institutions of higher education, nonprofits with 501(c)(3) status, for-profit organizations, small businesses, foreign organizations, and consortia. Applicants must demonstrate an established institutional presence in Kenya and a documented history of collaboration with the Kenya Medical Research Institute (KEMRI) and/or Kenya Ministry of Health.
The award provides $30 million in total program funding over a 5-year period divided into 12-month budget periods. The maximum award per budget period is $6 million, with Year 1 allocations of $2 million to $3 million for influenza and other respiratory pathogens, $75,000 to $100,000 for vaccine-preventable diseases, $400,000 for drug-resistant infections, and $100,000 for global and emerging health threats. Applicants must address all four priority areas; no individual priority will be funded separately.
Research will be conducted in Kenya through KEMRI and will focus on surveillance and monitoring of high-risk groups, assessment of disease burden and vaccine effectiveness, monitoring of antimicrobial resistance trends, and research on malaria, HIV, tuberculosis, schistosomiasis, and emerging infections. The recipient must also conduct research coordination and administration activities to manage U.S. government-funded research and ensure compliance with financial and ethical standards.
Applicants must submit separate applications for each of the four priority areas and provide a consolidated translation and dissemination plan. An optional letter of intent is due May 23, 2026. The expected award date is September 1, 2026, with a September 30, 2026 start date.
Assistance Listing / CFDA Number: 93.326.
Synopsis
This notice of funding opportunity (NOFO) supports research, implementation science, and public health evaluations to inform best practices for preventing and responding to infectious disease threats in Kenya, while strengthening local research capacity.The award recipient will conduct research, implementation science, and public health evaluations through the Kenya Medical Research Institute (KEMRI) and focus on four required priority areas:Influenza and other respiratory pathogens: Activities include surveilling high-risk groups; monitoring for human and avian influenza and other pathogens; and evaluating efficacy and use of vaccines and other treatments. Outcomes include increasing understanding of disease burden and improving vaccination strategies.Vaccine-preventable diseases: Research will assess disease burden, vaccine effectiveness, and sociocultural factors influencing immunization. Outcomes include increasing vaccine uptake and strengthening immunization systems.Drug-resistant infections: Activities include monitoring antimicrobial resistance (AMR) trends, applying novel diagnostics, and identifying drivers of resistance. Outcomes include improving mitigation strategies and global AMR preparedness.Global and emerging health threats: Research will address malaria, HIV, tuberculosis, schistosomiasis, and emerging infections. Outcomes include improving understanding of disease dynamics, intervention effectiveness, and cross-border risks.The recipient will also conduct research coordination and administration activities to manage and oversee U.S. government-funded public health research, ensure compliance with financial and ethical standards, and enhance organizational infrastructure. Outcomes include improved management and compliance with federal funding regulations.The proposed activities under this NOFO will generate evidence to guide U.S. and global preparedness, reduce disease burden and health threats in Kenya, and prevent the spread of health threats across borders.
Files
| File | Type | Posted |
|---|---|---|
| RFA-JG-26-034_Questions and Answers.pdf | ||
| rfa-jg-26-034_rev10.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity